These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17265020)

  • 1. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
    Matsueda S; Yamada A; Takao Y; Tamura M; Komatsu N; Yutani S; Ide T; Sata M; Itoh K
    Cancer Immunol Immunother; 2007 Sep; 56(9):1359-66. PubMed ID: 17265020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.
    Takedatsu H; Shichijo S; Katagiri K; Sawamizu H; Sata M; Itoh K
    Clin Cancer Res; 2004 Feb; 10(3):1112-20. PubMed ID: 14871991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
    Matsueda S; Takedatsu H; Yao A; Tanaka M; Noguchi M; Itoh K; Harada M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6933-43. PubMed ID: 16203785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
    Wang Y; Takao Y; Harada M; Yutani S; Ide T; Sata M; Itoh K; Yamada A
    Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.
    Takao Y; Yamada A; Yutani S; Takedatsu H; Ono T; Etoh K; Wang Y; Suzuki S; Ide T; Shimotohno K; Sata M; Itoh K
    Hepatol Res; 2007 Mar; 37(3):186-95. PubMed ID: 17362301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
    Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capability of SART3(109-118) peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles.
    Mohamed ER; Naito M; Terasaki Y; Niu Y; Gohara S; Komatsu N; Shichijo S; Itoh K; Noguchi M
    Int J Oncol; 2009 Feb; 34(2):529-36. PubMed ID: 19148489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11
    Sakamoto S; Matsueda S; Takamori S; Toh U; Noguchi M; Yutani S; Yamada A; Shichijo S; Yamada T; Suekane S; Kawano K; Naitou M; Sasada T; Hattori N; Kohno N; Itoh K
    Cancer Sci; 2017 Apr; 108(4):598-603. PubMed ID: 28178396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
    Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF
    J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.
    Tamura M; Yamada A; Takao Y; Matsueda S; Komatsu N; Yutani S; Ide T; Sata M; Itoh K
    Hepatol Res; 2005 Aug; 32(4):227-34. PubMed ID: 16095964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.
    Matsueda S; Takedatsu H; Sasada T; Azuma K; Ishihara Y; Komohara Y; Noguchi M; Shichijo S; Itoh K; Harada M
    J Immunother; 2007 Apr; 30(3):274-81. PubMed ID: 17414318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.
    Wang RF; Johnston SL; Southwood S; Sette A; Rosenberg SA
    J Immunol; 1998 Jan; 160(2):890-7. PubMed ID: 9551926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.
    Takao Y; Yamada A; Yutani S; Sata M; Itoh K
    Microbiol Immunol; 2004; 48(7):507-17. PubMed ID: 15272196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG
    J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG
    J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.
    Sasada T; Takedatsu H; Azuma K; Koga M; Maeda Y; Shichijo S; Shoumura H; Hirai T; Takabayashi A; Itoh K
    Cancer Res; 2004 Apr; 64(8):2882-8. PubMed ID: 15087407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
    PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.